Stefan Schreiber

Active 1991–2025

527
Papers
138,830
Citations
188
h-index
503
i10-index

Citations

Citations per year for Stefan Schreiber1971: 1 citations1972: 1 citations1985: 1 citations1987: 1 citations1991: 9 citations1992: 3 citations1993: 9 citations1994: 5 citations1995: 19 citations1996: 20 citations1997: 48 citations1998: 66 citations1999: 90 citations2000: 111 citations2001: 106 citations2002: 206 citations2003: 315 citations2004: 360 citations2005: 450 citations2006: 500 citations2007: 642 citations2008: 764 citations2009: 1,104 citations2010: 1,326 citations2011: 1,622 citations2012: 1,502 citations2013: 1,796 citations2014: 1,938 citations2015: 1,850 citations2016: 1,620 citations2017: 1,768 citations2018: 1,637 citations2019: 4,222 citations2020: 4,421 citations2021: 4,424 citations2022: 3,714 citations2023: 2,992 citations2024: 4,063 citations2025: 2,049 citations2026: 80 citations1973–1984: no citations, so these years are not shown1986: no citations, so this year is not shown1988–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 13,643 citing papers, 21.7% of this breakdownUnited Kingdom: 5,081 citing papers, 8.1% of this breakdownChina: 4,822 citing papers, 7.7% of this breakdownGermany: 4,678 citing papers, 7.4% of this breakdownItaly: 2,925 citing papers, 4.6% of this breakdownCanada: 2,778 citing papers, 4.4% of this breakdownFrance: 2,552 citing papers, 4.1% of this breakdownNetherlands: 2,255 citing papers, 3.6% of this breakdownAustralia: 1,776 citing papers, 2.8% of this breakdownSpain: 1,698 citing papers, 2.7% of this breakdownJapan: 1,573 citing papers, 2.5% of this breakdownSwitzerland: 1,354 citing papers, 2.1% of this breakdown
0%21.7%Other 28.3%

Fields

  • Biochemistry, Genetics and Molecular Biology46.9%
  • Medicine34.2%
  • Immunology and Microbiology8.8%
  • Neuroscience3.5%
  • Computer Science1.3%
  • Agricultural and Biological Sciences1.3%
  • Other4%

Topics

  • Inflammatory Bowel Disease7%
  • Gut microbiota and health4.7%
  • Genetic Associations and Epidemiology2.3%
  • Microscopic Colitis2.2%
  • Clostridium difficile and Clostridium perfringens research1.5%
  • Rheumatoid Arthritis Research and Therapies1.3%
  • Other81%

Coauthors

All papers

Open in search
  1. Swarm Learning for decentralized and confidential clinical machine learning

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena De Domenico, Christian Siever, Michael Kraut, Milind Y. Desai, Bruno Monnet, Maria Saridaki, Charles Siegel, Anna Drews, Melanie Nuesch-Germano, Heidi Theis, Jan Heyckendorf, Stefan Schreiber, Sarah Kim-Hellmuth, COVID-19 Aachen Study (COVAS), Paul Balfanz, Thomas Eggermann, Peter Boor, Ralf Hausmann, Hannah Kuhn, Susanne Isfort, Julia Stingl, Günther Schmalzing, Christiane Kühl, Rainer Röhrig, Gernot Marx, Stefan Uhlig, Edgar Dahl, Dirk Müller‐Wieland, Michael Dreher, Nikolaus Marx, Jacob Nattermann, Dirk Skowasch, Ingo Kurth, Andreas Keller, Robert Bals, Peter Nürnberg, Olaf Rieß, Philip Rosenstiel, Mihai G. Netea, Fabian J. Theis, Sach Mukherjee, Michael Backes, Anna C. Aschenbrenner, Thomas Ulas, Deutsche COVID-19 Omics Initiative (DeCOI), Angel Angelov, Alexander Bartholomäus, Anke Becker, Daniela Bezdan, Conny Blumert, Ezio Bonifacio, Peer Bork, Boyke Bunk, Helmut Blum, Thomas Clavel, Maria Colomé‐Tatché, Markus Cornberg, Inti Alberto De La Rosa Velázquez, Andreas Diefenbach, Alexander Dilthey, Nicole Fischer, Konrad U. Förstner, Sören Franzenburg, Julia-Stefanie Frick, Gisela Gabernet, Julien Gagneur, Tina Ganzenmueller, Marie Gauder, Janina Geißert, Alexander Goesmann and 81 more - Nature 2021 cited by 880

  2. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabrielle Boucher, Stephan Brand, Carsten Büning, Ariella Cohain, Sven Cichon, Mauro D’Amato, Dirk de Jong, Kathy L. Devaney, Marla C. Dubinsky, Cathryn Edwards, David Ellinghaus, Lynnette Ferguson, Denis Franchimont, Karin Fransén, Richard B. Gearry, Michel Georges, Christian Gieger, Jürgen Glas, Talin Haritunians, Ailsa Hart, Chris Hawkey, Matija Hedl, Xinli Hu, Tom H. Karlsen, Limas Kupčinskas, Subra Kugathasan, Anna Latiano, Debby Laukens, Ian C. Lawrance, Charlie W. Lees, Édouard Louis, Gillian Mahy, John Mansfield, Angharad R. Morgan, Craig Mowat, William G. Newman, Orazio Palmieri, Cyriel Y. Ponsioen, Uroš Potočnik, Natalie J. Prescott, Miguel Regueiro, Jerome I. Rotter, Richard K. Russell, Jeremy Sanderson, Miquel Sans, Jack Satsangi, Stefan Schreiber, Lisa A. Simms, Jurgita Šventoraitytė, Stephan R. Targan, Kent D. Taylor, Mark Tremelling, Hein W. Verspaget, Martine De Vos, Cisca Wijmenga, David C. Wilson, Juliane Winkelmann, Ramnik J. Xavier, Sebastian Zeißig, Bin Zhang, Hu Zhang, Hongyu Zhao, Mark S. Silverberg, Vito Annese, Håkon Håkonarson, Steven R. Brant, Graham Radford‐Smith, Christopher G. Mathew, John D. Rioux, Eric E. Schadt and 6 more - Nature 2012 cited by 4,917

  3. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 1,727

  4. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2017 cited by 586

  5. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet 2023 cited by 333

  6. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Ferrante - The Lancet 2022 cited by 387

  7. Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

    Authors: , , , , , , , , , , , , , , , , , , , , - Canadian Journal of Gastroenterology 2005 cited by 3,392

  8. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 437

  9. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 912

  10. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geert D’Haens - The Lancet 2022 cited by 316

  11. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    Authors: , , , , , , , , , , - The Lancet 2002 cited by 4,163

  12. Transcriptome and genome sequencing uncovers functional variation in humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helena Kilpinen, Sergi Beltrán, Marta Gut, Katja Kahlem, Vyacheslav Amstislavskiy, Oliver Stegle, Matti Pirinen, Stephen B. Montgomery, Peter Donnelly, Mark I. McCarthy, Paul Flicek, Tim M. Strom, Hans Lehrach, Stefan Schreiber, Ralf Sudbrak, Ángel Carracedo, Stylianos E. Antonarakis, Robert Häsler, Ann‐Christine Syvänen, Gert‐Jan B. van Ommen, Alvis Brāzma, Thomas Meitinger, Philip Rosenstiel, Roderic Guigó, Marta Gut, Xavier Estivill, Emmanouil T. Dermitzakis - Nature 2013 cited by 2,195

  13. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection

    Authors: , , , , , , , , , , , - Gastroenterology 2016 cited by 710

  14. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cisca Wijmenga, Robert N. Baldassano, Murray L. Barclay, Theodore M. Bayless, Stephan Brand, Carsten Büning, Albert Cohen, J F. Colombel, Mario Cottone, Laura Stronati, Ted Denson, Martine De Vos, R. D’Incà, Marla C. Dubinsky, Cathryn Edwards, Tim Florin, Denis Franchimont, Richard B. Gearry, Jürgen Glas, A. Van Gossum, Stephen L. Guthery, Jonas Halfvarson, Hein W. Verspaget, Jean‐Pierre Hugot, Amir Karban, Debby Laukens, Ian C. Lawrance, Marc Lémann, Arie Levine, Cécile Libioulle, Édouard Louis, Craig Mowat, William G. Newman, Julián Panés, Anne Phillips, Deborah D. Proctor, Miguel Regueiro, Richard K. Russell, Paul Rutgeerts, Jeremy Sanderson, Miquel Sans, Frank Seibold, A. Hillary Steinhart, Pieter Stokkers, Leif Törkvist, Gerd A. Kullak‐Ublick, David C. Wilson, Thomas D. Walters, Stephan R. Targan, Steven R. Brant, John D. Rioux, Mauro D’Amato, Rinse K. Weersma, Subra Kugathasan, Anne M. Griffiths, John Mansfield, Séverine Vermeire, Richard H. Duerr, Mark S. Silverberg, Jack Satsangi, Stefan Schreiber, Judy H. Cho, Vito Annese, Håkon Håkonarson, Mark J. Daly, Miles Parkes - Nature Genetics 2010 cited by 2,581

  15. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 725

  16. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 1,284

  17. openalex_id:w2145813488

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monika Stoll, Klaus Berger, Nicola Martinelli, Domenico Girelli, Pascal McKeown, Christopher Patterson, Stephen E. Epstein, Joseph M. Devaney, Mary-Susan Burnett, Vincent Mooser, Samuli Ripatti, Ida Surakka, Markku S. Nieminen, Juha Sinisalo, Marja‐Liisa Lokki, Markus Perola, Aki S. Havulinna, Ulf dé Fairé, Bruna Gigante, Erik Ingelsson, Tanja Zeller, Philipp S. Wild, Paul I. W. de Bakker, Olaf H. Klungel, Anke H. Maitland‐van der Zee, Bas Peters, Anthonius de Boer, Diederick E. Grobbee, Pieter W. Kamphuisen, Vera H.M. Deneer, Clara C. Elbers, N. Charlotte Onland‐Moret, Marten H. Hofker, Cisca Wijmenga, W. M. Monique Verschuren, Jolanda M.A. Boer, Yvonne T. van der Schouw, Asif Rasheed, Philippe Frossard, Serkalem Demissie, Cristen J. Willer, Ron Do, José M. Ordovás, Gonçalo R. Abecasis, Michael Boehnke, Karen L. Mohlke, Mark J. Daly, Candace Guiducci, Noël P. Burtt, Aarti Surti, Elena González, Shaun Purcell, Stacey Gabriel, Jaume Marrugat, John F. Peden, Jeanette Erdmann, Patrick Diemert, Christina Willenborg, Inke R. König, Marcus Fischer, Christian Hengstenberg, Andreas Ziegler, Ian Buysschaert, Diether Lambrechts, Frans Van de Werf, Keith A.A. Fox, Nour Eddine El Mokhtari, Deborah C. Rubin, Jürgen Schrezenmeir, Stefan Schreiber and 26 more cited by 2,293

  18. Genome-wide association study reveals genetic risk underlying Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katrina Gwinn, Marcel van der Brug, Grisel Lopez, Stephen J. Chanock, Arthur Schatzkin, Yikyung Park, Albert R. Hollenbeck, Jianjun Gao, Xuemei Huang, Nick W Wood, Delia Lorenz, Günther Deuschl, Honglei Chen, Olaf Rieß, John Hardy, Andrew Singleton, Thomas Gasser - Nature Genetics 2009 cited by 1,954

  19. XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease

    Authors: , , , , , , , , , , - Cell 2008 cited by 1,402

  20. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2020 cited by 317

  21. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2021 cited by 250

  22. Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2021 cited by 227

  23. Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

    Authors: , , , , , , , , , , - Gastroenterology 2006 cited by 2,250

  24. Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,128